08-Jun-17 Safe and effective materials dedicated to innovative packaging solutions for the healthcare and pharmaceutical market will be exhibited by Clariant at the CPhI China exhibition. With its large population base, China has emerged to become the second biggest healthcare market in the world and also the biggest producer and exporter of pharmaceutical ingredients. With the pharmaceutical industry continuing its development in China, coupled with the rising awareness on safety and quality standard among the average individuals, the demand is growing for more advanced packaging solutions that offer innovative features. Clariant has successfully leveraged its established technological advances in active materials, functional design and innovative plastic processing to offer the industry a host of packaging solutions capable of protecting pharmaceuticals from moisture and oxygen. In CPhI China, Clariant is featuring the following leading solutions:
Clariant's HAT (Handy Active Tubes) are durable, rigid containers with a convenient flip-top cap and built-in desiccant. The HAT line of flip-top tubes is an ideal vial for diagnostic test strips, as well as pharmaceuticals such as effervescent tablets, chewables and lozenges. By leveraging Clariant's ADP (Advanced Desiccant Polymer) technology that combines the advantages of traditional thermoplastic polymers with the benefits of advanced moisture protection, HAT products can be embedded with desiccant directly into the plastic, adsorbing excess humidity and creating a dry package environment. By working directly with Clariant's experts, specific polymers can be developed with calibrated kinetics and capacities dedicated to the needs of the customers, who may choose to mold existing working device components with ADP, adding moisture adsorption on top of the component's original function to save space and cost.
Clariant's EQ-PAK packets and EQ-CAN canisters are specially engineered sorbents that can act as humectants (desorbers) and desiccants (adsorbers) simultaneously, maintaining a particular equilibrium relative humidity (ERH) inside product packaging. Such condition of maintaining a constant humidity is sometimes critical to the effective storage of particular drugs. For instance, the ability of a micronized drug powder to reach optimally into a patient’s lungs when dispensed by a dry-powder inhaler (DPI) can be strongly influenced by moisture. Excessive moisture can increase adhesive or cohesive forces between particles and alter particle size distribution. Excessive dehydration, on the other hand, will increase the electrostatic charge of the particles. Both can adversely affect the fluidization of the powder when patients inhale. The EQ line of products comply with all relevant US FDA regulations for contact with food and drugs. It is available in both packets and canisters depending on the application. Packets are ideal for DPIs or other flexible packaging applications, whereas canisters are conducive to high speed automatic insertion into pharmaceutical bottles.
Previous News
Next News
{{comment.DateTimeStampDisplay}}
{{comment.Comments}}